9.29

0.43% 0.04

Pre-market: 9.30 0.01 +0.11%

Elicio Therapeutics Inc (ELTX)

Overview News Price History Discussions Forecast

Elicio Therapeutics Inc stock is traded at $9.29, with a volume of 80,851. It is up +0.43% in the last 24 hours and down -15.08% over the past month. Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Previous Close:

$9.25

Open:

$9.29

24h Volume:

80,851

Relative Volume:

0.81

Market Cap:

$151.78M

Revenue:

Net Income/Loss:

$-33.82M

P/E Ratio:

-0.363

EPS:

-25.5891

Net Cash Flow:

$-66.04M

1W Performance:

-4.23%

1M Performance:

-15.08%

6M Performance:

+88.82%

1Y Performance:

+118.08%

1-Day Range:

$9.165

$9.41

1-Week Range:

$9.14

$10.22

52-Week Range:

$4.2283

$12.62

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Name

Elicio Therapeutics Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(857) 209-0050

Address

451 D STREET, 5TH FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

ELTX's Discussions on Twitter

Compare ELTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELTX Elicio Therapeutics Inc	9.29	151.13M	0	-33.82M	-66.04M	-25.59
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Elicio Therapeutics Inc Stock (ELTX) Latest News

02:15 AM

How high can Elicio Therapeutics Inc. stock goEarnings Recap Report & Daily Growth Stock Tips - newser.com

02:15 AM

02:05 AM

How Elicio Therapeutics Inc. (9HA) stock moves in volatile trading sessions2025 Top Decliners & Safe Capital Growth Tips - newser.com

02:05 AM

01:26 AM

Can Elicio Therapeutics Inc. stock weather global recessionJuly 2025 Breakouts & Safe Capital Growth Tips - newser.com

01:26 AM

01:15 AM

Analyzing net buyer seller activity in Elicio Therapeutics Inc.Watch List & Entry Point Confirmation Signals - newser.com

01:15 AM

12:17 PM

Using economic indicators to assess Elicio Therapeutics Inc. potentialBear Alert & Safe Capital Growth Tips - newser.com

12:17 PM

12:03 PM

Statistical indicators supporting Elicio Therapeutics Inc.’s strength2025 Market Outlook & Reliable Breakout Forecasts - newser.com

12:03 PM

Nov 02, 2025

Can Elicio Therapeutics Inc. (9HA) stock attract ESG investmentsEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 02, 2025

Is Elicio Therapeutics Inc. stock oversold or undervaluedWeekly Loss Report & Weekly Breakout Stock Alerts - newser.com

Nov 02, 2025

How Elicio Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com

Nov 02, 2025

Is Elicio Therapeutics Inc. (9HA) stock bottoming after sell offJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com

Nov 02, 2025

Nov 01, 2025